Gynecologic

Gynecologic Cancer Treatment Trials

Protocol
Number

Title

ID

GOG
0274

A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial

Learn more.

NCT01414608
GOG
0277

A Phase III Randomized Trial of Gemcitabine (NSC# 613327) Plus Docetaxel (NSC# 628503) Followed by Doxorubicin (NSC# 123127) v. Observation for Uterus-Limited, High Grade Uterine Leiomyosarcoma

Learn more.

NCT01533207
GOG
3001

The purpose of this study is to determine whether AMG 386 or AMG 386 Placebo in combination with Paclitaxel and Carboplatin are effective in the treatment of ovarian cancer.

Learn more.

NCT01493505
GOG
0273

Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Learn more.

NCT01366183
GOG
0263

Randomized Phase III Clinical Trial of Adjuvant Radiation vs. Chemoradiation in Intermediated Risk Stage I/IIA Cervical Cancer Treated w/ Initial Radical Hysterectomy & Pelvic Lymphadenectomy

Learn more.

NCT01101451
GOG
0241

A Multi-Center Phase III Trial of Open Label of Carboplatin & Paclitaxel +/-NCI Supplied Agent: Bevacizumab Compared with Oxaliplatin & Capecitabine +/- Bevacizumab as First Line Chemotherapy in Patients with Mucinous Epithelial Ovarian or Fallopian Tube Cancer (MEOC)

Learn more.

NCT01081262
GOG
0258

A Randomized Phase III Trial of Cisplatin & Tumor Volume Directed Irradiation followed by Carboplatin & Paclitaxel vs Carboplatin & Paclitaxel for Optimally Advanced Endometrial Carcinoma

Learn more.

NCT00942357